课题基金 / 基金详情

Molecular mechanisms of cytokine-induced modulation of T cell antigen receptor responsiveness

Molecular mechanisms of cytokine-induced modulation of T cell antigen receptor responsiveness
细胞因子诱导的 T 细胞抗原受体反应性调节的分子机制
批准号:
RGPIN-2020-04804
负责人:
Ilangumaran, Subburaj
金额:
$2.33万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-01-01 至 2021-12-31

项目摘要

项目成果

Ilangumaran, Subburaj的其他基金

相似基金

相关文献

中文摘要
翻译
本研究计划的总体目标是了解先天免疫应答过程中产生的炎性细胞因子如何影响细胞毒性T淋巴细胞的适应性免疫应答。 细胞因子应答受细胞因子信号传导抑制因子(SOCS)家族蛋白调节。 在研究缺乏SOCS 1的小鼠中T细胞区室的失调稳态时,我们偶然观察到:SOCS 1缺陷的CD 8 T细胞响应于调节T细胞稳态的细胞因子而稳健增殖,并且这被炎性细胞因子放大;虽然这并不意外,但来自对照小鼠的CD 8 T细胞也响应于炎性和稳态细胞因子的协同刺激而增殖。后者是出乎意料的,因为正常的T细胞需要两个信号,一个通过抗原受体,另一个通过共刺激受体。由于炎症和稳态细胞因子在炎症条件下(响应于感染或无菌炎症)都可以获得,我们开始研究这种抗原和共刺激非依赖性活化原始T细胞的生理意义和病理后果。 在过去的十年中,我们已经表明,(i)由于它们对有限量的抗原和弱激动性抗原肽做出反应,所以烟碱刺激的T细胞获得对抗原的敏感性增加,(ii)这种抗原非特异性刺激可以在体内激活自身反应性T细胞,以及(iii)该过程受SOCS 1调节。我们还发现,经精氨酸致敏的T细胞显示出代谢适应性增加和其质膜的显著变化,这可能影响T细胞抗原受体(TCR)信号传导。在拟议的研究中,我们的目标是了解的机制和分子基础的抗原反应性增加的马槟榔引发的T细胞。 由于我们的候选方法显示出非常有限的范围,我们建议使用无偏的基因组学(ATACseq,RNAseq)和蛋白质组学(iTRAQ差异蛋白质组学)方法来获得细胞因子引发期间发生的分子变化的全面视图。将使用体外试验和体内模型测试所选候选基因/蛋白质/途径对细胞因子引发的贡献。 拟议的研究计划将侧重于培养学生在基因组学和蛋白质组学,生物信息学分析的前沿技术。此外,他们将接受与动物处理,T细胞生物学,流式细胞术,共聚焦显微镜,分子生物学技术和生物信息学分析相关的几种免疫学技术的培训。学员将获得适合学术生涯和行业工作的知识和技能。 这项研究的结果将影响如何利用细胞因子来增强免疫反应,以及如何靶向它们的信号通路来控制异常的免疫反应。
英文摘要
The overall objective of this research program is to understand how inflammatory cytokines produced during innate immune responses impact on the adaptive immune responses of cytotoxic T lymphocytes. Cytokine responses are regulated by suppressors of cytokine signaling' (SOCS) family proteins. While studying the deregulated homeostasis of the T cell compartment in mice lacking SOCS1, we made a fortuitous observation: SOCS1-deficient CD8 T cells proliferate robustly in response to cytokines that regulate T cell homeostasis and this is amplified by inflammatory cytokines; while this was not unexpected, CD8 T cells from control mice also proliferated in response to synergistic stimulation by inflammatory and homeostatic cytokines. The latter was unexpected because normal T cells require two signals one via the antigen receptor and the other via a costimulatory receptor. As both inflammatory and homeostatic cytokines can become available during inflammatory conditions (in response to infections or sterile inflammation), we started investigating the physiological significance and pathological consequences of such antigen- and co-stimulation- independent activation of nave T cells. Over the past decade, we have shown that (i) the cytokine-stimulated T cells acquire increased sensitivity to antigens as they respond to limiting amounts of antigens and weakly agonistic antigenic peptides, (ii) such antigen non-specific stimulation can activate autoreactive T cells in vivo, and (iii) this process is regulated by SOCS1. We have also found that the cytokine-primed' T cells display increased metabolic fitness and marked changes in their plasma membrane that could impact T cell antigen receptor (TCR) signaling. In the proposed research, we aim to understand the mechanistic and molecular basis of the increased antigen responsiveness of cytokine-primed T cells. As our candidate approaches have shown very limited scope, we propose to use unbiased genomic (ATACseq, RNAseq) and proteomic (iTRAQ differential proteomics) approaches to gain a comprehensive view of the molecular changes that occur during cytokine priming. The selected candidate genes/proteins/pathways will be tested for their contribution to cytokine priming using in vitro assays and in vivo models. The proposed research program will put emphasis on training students in cutting-edge technologies of genomics and proteomics, and bioinformatics analyses. In addition they will be trained in several immunology techniques related to animal handling, T cell biology, flow cytometry, confocal microscopy, molecular biology techniques and bioinformatics analyses. The trainees will gain knowledge and skill set suitable for both academic career and industry jobs. The outcome of this research will impact on how cytokines could be exploited for boosting immune responses, and how their signaling pathways could be targeted to control aberrant immune responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular mechanisms of cytokine-induced modulation of T cell antigen receptor responsiveness
  • 批准号:
    RGPIN-2020-04804
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.33万
  • 财政年份:
    2022
  • 负责人:
    Ilangumaran, Subburaj
  • 依托单位:
Molecular mechanisms of cytokine-induced modulation of T cell antigen receptor responsiveness
  • 批准号:
    RGPIN-2020-04804
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.33万
  • 财政年份:
    2021
  • 负责人:
    Ilangumaran, Subburaj
  • 依托单位:
Cytokine-induced modulation of T lymphocyte responses to antigens
  • 批准号:
    RGPIN-2014-04692
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.55万
  • 财政年份:
    2018
  • 负责人:
    Ilangumaran, Subburaj
  • 依托单位:
Cytokine-induced modulation of T lymphocyte responses to antigens
  • 批准号:
    RGPIN-2014-04692
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.55万
  • 财政年份:
    2017
  • 负责人:
    Ilangumaran, Subburaj
  • 依托单位:
国内基金
海外基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI Z
  • 依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
  • 批准号:
    W2433169
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI ZHANG
  • 依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
  • 批准号:
    82371255
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    曹立
  • 依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
  • 批准号:
    82370979
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张善勇
  • 依托单位: